A Phase 3b/4 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Verify the Clinical Benefit of Aducanumab (BIIB037) in Participants with Alzheimer's Disease
Details
Age
Adult
Type of Study
Treatment
Locations
Brain Imaging Center (BIC)
CU-RIC
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Victoria Pelak, MD
Study ID
Protocol Number: 22-0776
More information available at ClinicalTrials.gov: NCT05310071
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers